Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$35.77 - $51.11 $536,550 - $766,650
-15,000 Reduced 37.5%
25,000 $1.15 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $1.54 Million - $2.18 Million
40,000 New
40,000 $12.6 Million
Q4 2019

Feb 14, 2020

SELL
$7.95 - $11.84 $1.5 Million - $2.23 Million
-188,096 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$10.82 - $14.25 $2.04 Million - $2.68 Million
188,096 New
188,096 $2.14 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.93B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.